Skip to content
Search

Latest Stories

Bristol Myers Squibb becomes UK's first pharma company to be accredited as 'menopause friendly'

Pharmaceutical giant Bristol Myers Squibb has become the first pharmaceutical company in the UK to be accredited as a 'menopause friendly workplace'.

The accreditation, awarded by an independent panel of judges, recognises employers who put diversity, inclusion and wellbeing at the centre stage of their business.


Bristol Myers Squibb (BMS) said it rung in the changes in recognition of the fact that nearly eight of 10 menopausal women are in work and that this is the fastest growing demographic in the workforce.

Panel members described BMS UK&I’s application as “outstanding” and acknowledged "the huge strides they have made to help normalise the menopause" by fostering an inclusive culture.

Support and education

The company said it has pioneered a range of menopause-friendly initiatives to support women at work since last March which include:

• A detailed internal menopause guidance document to support and educate all UK&I staff

o This includes details on the different types of menopause, how symptoms can affect daily work, and signposting to internal and external resources

• A reasonable adjustments form to help accommodate staff experiencing menopausal symptoms

• A Rapid Access Female Treatment Service (RAFT) that allows employees experiencing severe menopausal symptoms in the workplace to be referred to a consultant gynaecologist who is an accredited British Menopause Society specialist

• Training 17 menopause advocates across UK&I sites who help educate, raise awareness, and signpost colleagues on their menopause journey

• A menopause portal developed for employees, by employees, to access support and information

• Training more than 60 per cent of the UK&I workforce on menopause awareness

Scott Cooke, general manager for BMS UK&I, said: “I am so proud that Bristol Myers Squibb UK&I is the first pharmaceutical company to have been officially awarded Menopause Friendly status, highlighting our continued commitment to ensuring that all people affected by the menopause feel supported at work.

"I am delighted that we are helping lead the way in changing how businesses think about the menopause, and we remain passionate about accelerating change in workplace best practice and fostering an inclusive culture where everyone can bring their authentic selves to work every day.”

Members of the accreditation board include Professor Jo Brewis, lead author of the Government Equalities Office report on ‘The effects of menopause transition on women’s economic participation in the UK’, and Bernice Allport MBE, former chair of the cross-government Menopause Network.

More For You

Youth vaping : project to examine health impacts on children

Youth vaping : project to examine health impacts on children

Youth vaping: £62M research project to examine health impacts on children

The UK government has announced a £62 million research project to investigate the long-term health effects of vaping on young people, alongside wider influences on adolescent health and wellbeing.

While vaping is considered less harmful than smoking and can aid adult smokers in quitting, youth vaping has skyrocketed in recent years, with a quarter of 11 to 15-year-olds having tried it, the Department of Health and Social Care (DHSC) noted in a release.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Following the conclusion of a nomination process last week, Baldev Bange, Aisling O’Brien, Sehar Shahid, and Sanjay Ganvir have been re-elected to the Board, representing areas of England and Scotland, according to a statement from NPA.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

The report, How medicines optimisation contributes to population health, published recently by policy institute Public Policy Projects, highlighted that non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed.

Keep ReadingShow less
GHP calls for 10% mandated protected learning time for NHS pharmacists in new campaign
Many pharmacists end up doing ‘unpaid work’ to catch up with the required training (gettyimages)

Increase protected learning time for NHS pharmacists – GHP launches national campaign

Many pharmacists end up doing ‘unpaid work’ to catch up with the required training or completing self-learning in their own time.

The Guild of Healthcare Pharmacists (GHP) has launched a national campaign advocating for pharmacists working in the NHS to have a minimum of 10% of their contracted hours protected for supporting professional activities (SPA).

In a statement published on 7 February 2025, the GHP emphasised that this protected time “should be recognized by employers and embedded in job plans.”

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Kinnock made this statement in response to a written question from Nick Timothy, Conservative MP for West Suffolk, who asked the secretary of state for health and social care, if he will review the reimbursement system for pharmacies and GP practices dispensing medicines.

Keep ReadingShow less